| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.TIM.2007.03.005 |
| P698 | PubMed publication ID | 17398100 |
| P50 | author | Robert B. Sim | Q39994033 |
| P2093 | author name string | Sanjay Ram | |
| Christoph M Tang | |||
| Muriel C Schneider | |||
| Rachel M Exley | |||
| P433 | issue | 5 | |
| P921 | main subject | Neisseria meningitidis | Q154625 |
| P304 | page(s) | 233-240 | |
| P577 | publication date | 2007-03-29 | |
| P1433 | published in | Trends in Microbiology | Q15265732 |
| P1476 | title | Interactions between Neisseria meningitidis and the complement system | |
| P478 | volume | 15 |
| Q36699790 | A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies |
| Q30400787 | A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection |
| Q33418169 | A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups |
| Q28538344 | A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsule |
| Q34105747 | An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae |
| Q38234314 | Bacteria under stress by complement and coagulation. |
| Q37327589 | Bench-to-bedside review: Bacterial virulence and subversion of host defences. |
| Q37727051 | Biofilm formation by the human pathogen Neisseria meningitidis |
| Q34561839 | Cell cycle constraints on capsulation and bacteriophage susceptibility |
| Q33696949 | Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease |
| Q41922489 | Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein |
| Q91586659 | Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection |
| Q34796849 | Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups. |
| Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
| Q34753608 | Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility |
| Q35197120 | Complement evasion by Bordetella pertussis: implications for improving current vaccines |
| Q35026107 | Complement system in dermatological diseases - fire under the skin |
| Q35191862 | Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding |
| Q33613839 | Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies |
| Q89544439 | Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation in Neisseria meningitidis |
| Q27675010 | Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules |
| Q36211092 | Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H. |
| Q49895490 | Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX |
| Q55340735 | Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX. |
| Q34916886 | Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein |
| Q42173007 | Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity |
| Q33979760 | Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin |
| Q33614888 | Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter. |
| Q41825787 | Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. |
| Q36708689 | Functional dissection of Toxoplasma gondii perforin-like protein 1 reveals a dual domain mode of membrane binding for cytolysis and parasite egress |
| Q34231871 | Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis |
| Q37862579 | Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis |
| Q34058392 | Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica |
| Q40393210 | Genome-wide association studies are coming for human infectious diseases |
| Q42076585 | Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst |
| Q45368813 | Glycoengineering of host mimicking type-2 LacNAc polymers and Lewis X antigens on bacterial cell surfaces |
| Q38386703 | HexR Controls Glucose-Responsive Genes and Central Carbon Metabolism in Neisseria meningitidis |
| Q37516016 | Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion. |
| Q31027494 | Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity |
| Q34237895 | Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding |
| Q38892814 | Immune evasion of leptospira species by acquisition of human complement regulator C4BP. |
| Q40813011 | Immune subversion and quorum-sensing shape the variation in infectious dose among bacterial pathogens. |
| Q36981181 | Immunological and genetic bases of new primary immunodeficiencies |
| Q34916705 | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. |
| Q28972389 | Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy |
| Q61293682 | Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection |
| Q36613357 | Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity |
| Q37693343 | Killing machines: three pore-forming proteins of the immune system |
| Q49410181 | Masking the Pathogen: Evolutionary Strategies of Fungi and Their Bacterial Counterparts |
| Q35138700 | Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay |
| Q43749260 | Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance |
| Q36421536 | MisR/MisS two-component regulon in Neisseria meningitidis. |
| Q28730934 | Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity |
| Q37932528 | Neisseria meningitidis B vaccines. |
| Q38328071 | Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates |
| Q34428168 | Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci |
| Q47171952 | Open housing drives the expression of immune response genes in the nasal mucosa, but not the olfactory bulb |
| Q37415301 | Pathogenic neisseriae: surface modulation, pathogenesis and infection control |
| Q36440358 | Prospects for eradication of meningococcal disease |
| Q40100649 | RNA-mediated signal perception in pathogenic bacteria |
| Q74441824 | RNAs at fever pitch |
| Q43894530 | Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes |
| Q35191828 | Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant |
| Q45004244 | Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report |
| Q37362174 | Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease |
| Q26995291 | Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration |
| Q47666318 | Species-specific differences in regulation of macrophage inflammation by the C3a-C3a receptor axis. |
| Q27715823 | Structure and mechanism of a molecular rheostat, an RNA thermometer that modulates immune evasion by Neisseria meningitidis |
| Q48030042 | Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development |
| Q42267002 | Temperature triggers immune evasion by Neisseria meningitidis |
| Q36139946 | The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection |
| Q34232221 | The Role of the Exopolyphosphatase PPX in Avoidance by Neisseria meningitidis of Complement-mediated Killing |
| Q37651436 | The biology of Neisseria adhesins. |
| Q35989852 | The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens |
| Q35936064 | The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci |
| Q37456620 | The role of complement in gonococcal infection of cervical epithelia |
| Q33963083 | The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease |
| Q33903848 | Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival |
| Q37130358 | fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations. |
Search more.